PAT-SC1

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePAT-SC1
Drug Alias NameSC-1PAT-SC1PAT-SC-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionComplement decay-accelerating factor modulatorsApoptosis stimulants
TargetsComplement decay-accelerating factor
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncomab Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesOncomab GmbhPatrys Ltd
Inactive CompaniesN/A
Active IndicationsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A